Cleared Traditional

K233801 - Nalu Neurostimulation System for Spinal Cord Stimulation (FDA 510(k) Clearance)

Also includes:
Nalu Neurostimulation System for Peripheral Nerve Stimulation
Aug 2024
Decision
268d
Days
Class 2
Risk

K233801 is an FDA 510(k) clearance for the Nalu Neurostimulation System for Spinal Cord Stimulation. This device is classified as a Stimulator, Spinal-cord, Implanted (pain Relief) (Class II - Special Controls, product code GZB).

Submitted by Boston Scientific Neuromodulation (Valencia, US). The FDA issued a Cleared decision on August 23, 2024, 268 days after receiving the submission on November 29, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5880.

Submission Details

510(k) Number K233801 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 29, 2023
Decision Date August 23, 2024
Days to Decision 268 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZB — Stimulator, Spinal-cord, Implanted (pain Relief)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5880